Clinical Trials Logo

Filter by:
NCT ID: NCT06374901 Not yet recruiting - Gastric Cancer Clinical Trials

Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.

Start date: April 25, 2024
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy of Tislelizumab in combination with chemotherapy versus chemotherapy in neoadjuvant treatment of patients with MHC-II positive (IHC≥2+) and locally advanced gastric/gastroesophageal junction adenocarcinoma by evaluating the main pathologic response rate (MPR).

NCT ID: NCT06374823 Not yet recruiting - Critical Care Clinical Trials

Multiple Electrolytes Injection (II) and Normal Saline on Hyperchloremia in Severe Hemorrhagic Stroke

MERIT
Start date: May 2024
Phase: Phase 4
Study type: Interventional

Normal saline (0.9% sodium chloride), a classical crystalloid solution, is widely used to maintain fluid balance, volume resuscitation and dilute drugs during clinical practice. However, the chloride concentration of normal saline (154mmol/L) is much higher than human plasma, and a large amount of infusion may lead to iatrogenic hyperchloremia in ICU patients. In contrast, the concentrations of Multiple electrolytes II is more similar to those of plasma and is considered to be a better fluid choice than normal saline.

NCT ID: NCT06373991 Not yet recruiting - Clinical trials for Lupus Erythematosus, Systemic

A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus

Start date: July 24, 2024
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to test ATHENA CAR-T injection in adults with moderate to severe Systemic Lupus Erythematosus. The main question it aims to answer is: • To evaluate the safety and tolerability of ATHENA CAR-T. After screening, participants will be subjected to lymphodepletion regimen. After recovery, participants will be injected with ATHENA CAR-T injection and followed up to 24 months.

NCT ID: NCT06373692 Not yet recruiting - Bronchial Asthma Clinical Trials

REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)

Start date: May 1, 2024
Phase:
Study type: Observational

The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma.

NCT ID: NCT06373094 Not yet recruiting - Alzheimer Disease Clinical Trials

A Single Dose Escalation Study of HHT201 in Healthy Subjects

Start date: June 1, 2024
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the safety and pharmacokinetic profiles of HHT201 in healthy subjects.

NCT ID: NCT06373029 Not yet recruiting - Ultrasound Clinical Trials

Deep-learning Enabled Ultrasound Diagnosis of Anterior Talofibular Ligament Injury

Start date: April 20, 2024
Phase:
Study type: Observational

Ultrasound (US) is a more cost-effective, accessible, and available imaging technique to assess anterior talofibular ligament (ATFL) injuries compared with magnetic resonance imaging (MRI). However, challenges in using this technique and increasing demand on qualified musculoskeletal (MSK) radiologists delay the diagnosis. The investigators have already developed a deep convolutional network (DCNN) model that automates detailed classification of ATFL injuries. The investigators hope to use the DCNN in real-world clinical setting to test its diagnostic accuracy.

NCT ID: NCT06372782 Not yet recruiting - Clinical trials for Skin Aging of Dorsal Hands

Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand

Start date: April 2024
Phase: N/A
Study type: Interventional

This is a randomized, multi-center, split-hand, subject-blinded study comparing pain, safety and effectiveness of Restylane Skinboosters Vital Lidocaine and Restylane Vital without lidocaine for improving appearance of the dorsal hands in Chinese subjects.

NCT ID: NCT06372678 Not yet recruiting - Clinical trials for Chronic Rhinosinusitis With Nasal Polyps

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Start date: June 30, 2024
Phase: Phase 2
Study type: Interventional

This is a multi-center, randomized, double blind, placebo-controlled Phase II study to evaluate the efficacy and safety of CM326, and to observe the Pharmacokinetics, Pharmacodynamics and immumogenicity of CM326 in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP).

NCT ID: NCT06372184 Not yet recruiting - Rhinitis, Allergic Clinical Trials

Washed Microbiota Transplantation for Allergic Rhinitis

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Allergic rhinitis (AR) is characterized by sneezing, nasal congestion, nasal itching and nasal leakage and is caused by immunoglobulin E (IgE)-mediated reactions to inhaled allergens. Increasing evidence showed that gut microbiota could influence the development of AR, and we found that washed microbiota transplantation (WMT) could improve nasal symptoms in clinical practice. This clinical trial aims to evaluate the efficacy and safety of WMT for AR.

NCT ID: NCT06371534 Not yet recruiting - Tumor Clinical Trials

A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults

Start date: April 2024
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to compare the pharmacokinetic and safety similarity of QL2109 with DARZALEX FASPRO® in healthy male volunteers. Participants will receive a single injection of QL2109/ DARZALEX FASPRO® Researchers will compare pharmacokinetic, safety, and immunogenic similarities between the two groups.